Atlas Trials

A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT04017130 · TERMINATED

Trial details

NCT number
NCT04017130
Sponsor
Molecular Templates, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2020-02-05
Primary completion
2023-12-13
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.